Abivax S.A. (0RA9.L) LSE

58.80

-1.2717(-2.12%)

Updated at August 19 10:00AM

Currency In EUR

Valuation

Market Cap426.19M
Enterprise Value379.33M
P/E Ratio-21.39
PEG Ratio-1.67
Price/Sales Ratio418.06
Price/Book Ratio92.91
Enterprise/Revenue413.61
Enterprise/EBITDA-26

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-16.33
Operating Margin-17.18

Management Effectiveness

Return On Assets-0.86
Return On Equity-2.11

Income Statement

Revenue10.79M
Revenue/Share0.17
Gross Profit10.79M
EBITDA-167.68M
Net Income-176.24M
Diluted EPS-2.8

Balance Sheet

Total Cash144.22M
Total Cash/Share2.28
Total Debt96.2M
Total Debt/Equity2.37
Current Ratio1.82
Book Value Per Share0.64

Price History

52-Week Change497.13
52-Week High60.2
52-Week Low5.68
Moving Average 50 Days11.44
Moving Average 200 Days13.25

Statistics

Average Volume5,413
Shares Outstanding75.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A